BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 398254)

  • 1. Piperonyl butoxide, alpha[2-(2-butoxyethoxy)ethoxy]-4,5-methylenedioxy-2-propyltoluene: a review of the literature.
    Haley TJ
    Ecotoxicol Environ Saf; 1978 Jun; 2(1):9-31. PubMed ID: 398254
    [No Abstract]   [Full Text] [Related]  

  • 2. Chronic toxicity studies of piperonyl butoxide in CD-1 mice: induction of hepatocellular carcinoma.
    Takahashi O; Oishi S; Fujitani T; Tanaka T; Yoneyama M
    Toxicology; 1997 Dec; 124(2):95-103. PubMed ID: 9457999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sub-acute toxicity of piperonyl butoxide in F344 rats.
    Fujitani T; Ando H; Fujitani K; Ikeda T; Kojima A; Kubo Y; Ogata A; Oishi S; Takahashi H; Takahashi O
    Toxicology; 1992; 72(3):291-8. PubMed ID: 1585383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carcinogenesis bioassay of technical-grade piperonyl butoxide in F344 rats.
    Cardy RH; Renne RA; Warner JW; Cypher RL
    J Natl Cancer Inst; 1979 Mar; 62(3):569-78. PubMed ID: 283286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular pathological analysis for determining the possible mechanism of piperonyl butoxide-induced hepatocarcinogenesis in mice.
    Muguruma M; Nishimura J; Jin M; Kashida Y; Moto M; Takahashi M; Yokouchi Y; Mitsumori K
    Toxicology; 2006 Dec; 228(2-3):178-87. PubMed ID: 17014948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Piperonyl butoxide.
    IARC Monogr Eval Carcinog Risk Chem Hum; 1983 Jan; 30():183-95. PubMed ID: 6578179
    [No Abstract]   [Full Text] [Related]  

  • 7. Piperonyl butoxide induces hepatocellular carcinoma in male CD-1 mice.
    Takahashi O; Oishi S; Fujitani T; Tanaka T; Yoneyama M
    Arch Toxicol; 1994; 68(7):467-9. PubMed ID: 7979964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanistic study on liver tumor promoting effects of piperonyl butoxide in rats.
    Okamiya H; Mitsumori K; Onodera H; Ito S; Imazawa T; Yasuhara K; Takahashi M
    Arch Toxicol; 1998 Nov; 72(11):744-50. PubMed ID: 9879813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolism and excretion of piperonyl butoxide in the rat.
    Byard J; Needham D
    Xenobiotica; 2006 Dec; 36(12):1259-72. PubMed ID: 17162471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subacute toxicity of piperonyl butoxide in ICR mice.
    Fujitani T; Tanaka T; Hashimoto Y; Yoneyama M
    Toxicology; 1993 Oct; 83(1-3):93-100. PubMed ID: 8248953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic toxicity studies of piperonyl butoxide in F344 rats: induction of hepatocellular carcinoma.
    Takahashi O; Oishi S; Fujitani T; Tanaka T; Yoneyama M
    Fundam Appl Toxicol; 1994 Feb; 22(2):293-303. PubMed ID: 7911767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute toxicity of permethrin/piperonyl butoxide on hybrid striped bass.
    Rebach S
    Bull Environ Contam Toxicol; 1999 Apr; 62(4):448-54. PubMed ID: 10094728
    [No Abstract]   [Full Text] [Related]  

  • 13. Purification and characterization of pesticidal synergists. I. Piperonyl butoxide.
    Albro PW; Fishbein L; Fawkes J
    J Chromatogr; 1972 Mar; 65(3):521-32. PubMed ID: 4335990
    [No Abstract]   [Full Text] [Related]  

  • 14. Morphometric and immunohistochemical studies on atrophic changes in lympho-hematopoietic organs of rats treated with piperonyl butoxide or subjected to dietary restriction.
    Mitsumori K; Takegawa K; Shimo T; Onodera H; Yasuhara K; Takahashi M
    Arch Toxicol; 1996; 70(12):809-14. PubMed ID: 8911638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Developmental toxicity study of piperonyl butoxide in CD rats.
    Tanaka T; Fujitani T; Takahashi O; Oishi S; Yoneyama M
    Toxicol Ind Health; 1995; 11(2):175-84. PubMed ID: 7491633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of in vivo liver genotoxic potential of Wy-14,643 and piperonyl butoxide in rats subjected to two-week repeated oral administration.
    Suzuki T; Jin M; Dewa Y; Ichimura R; Shimada Y; Mizukami S; Shibutani M; Mitsumori K
    Arch Toxicol; 2010 Jun; 84(6):493-500. PubMed ID: 20127075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pyrethroids and the synergist piperonyl-butoxide (PBO) affect T-cells and basophils.
    Diel F; Horr B; Detscher M; Sosnovikova L; Borck H
    Inflamm Res; 1999 Apr; 48 Suppl 1():S15-6. PubMed ID: 10350141
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of piperonyl butoxide on spontaneous behavior in F1-generation mice.
    Tanaka T; Takahashi O; Oishi S; Ogata A
    Toxicol Ind Health; 2009 Aug; 25(7):489-97. PubMed ID: 19783574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Temporal synergism by microencapsulation of piperonyl butoxide and alpha-cypermethrin overcomes insecticide resistance in crop pests.
    Bingham G; Gunning RV; Gorman K; Field LM; Moores GD
    Pest Manag Sci; 2007 Mar; 63(3):276-81. PubMed ID: 17304634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brain levels of 1 -tetrahydrocannabinol and its metabolites in mice--correlation with behaviour, and the effect of the metabolic inhibitors SKF 525A and piperonyl butoxide.
    Gill EW; Jones G
    Biochem Pharmacol; 1972 Aug; 21(16):2237-48. PubMed ID: 4674983
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.